SCHEMBL24724844

SCHEMBL24724844

COCCO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1N

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALOX15 P16050 1/20 0.42
HSD17B10 Q99714 1/20 0.40
TSHR P16473 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
MAPK1 P28482 1/20 0.39
IGF2R P11717 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 1/20 0.39
LRAT O95237 1/20 0.39
TRPV1 Q8NER1 1/20 0.39
LGALS8 O00214 1/20 0.38
LGALS3 P17931 1/20 0.38
LGALS4 P56470 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29184490 1.00 LMNA (0.42) LMNAKDM4EALOX15HSD17B10TSHR
SCHEMBL29184489 1.00 LMNA (0.42) LMNAKDM4EALOX15HSD17B10TSHR
SCHEMBL4593036 0.86 GAA (0.49) MAPK1L3MBTL1LGALS8LGALS3LGALS4
SCHEMBL16250343 0.85 CA1 (0.49) LMNAKDM4EALOX15HSD17B10TSHR
SCHEMBL28326643 0.85 CA1 (0.49) LMNAKDM4EALOX15HSD17B10TSHR
SCHEMBL11505243 0.85 CA1 (0.49) LMNAKDM4EALOX15HSD17B10TSHR
SCHEMBL11505240 0.85 CA1 (0.49) LMNAKDM4EALOX15HSD17B10TSHR
SCHEMBL7743930 0.85 GAA (0.51) IGF2RL3MBTL1LGALS8LGALS3LGALS4
SCHEMBL25312309 0.85 LMNA (0.45) LMNAKDM4EALOX15HSD17B10TSHR
SCHEMBL13686584 0.83 IGF2R (0.50) LMNAKDM4EALOX15HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235699-A2 POTENT ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS AVILAR THERAPEUTICS, INC. (US) 2022-11-10 WO disclosed
WO-2022235699-A2 POTENT ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS AVILAR THERAPEUTICS, INC. (US) 2022-11-10 WO disclosed